{"id":"W4379330912","doi":"10.1200/jco.2023.41.16_suppl.5012","title":"Health-related quality of life (HRQoL) and pain outcomes for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) who received abiraterone (abi) and olaparib (ola) versus (vs) abi and placebo (pbo) in the phase III PROpel trial.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Hospital; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Brief Pain Inventory; Prostate cancer; Hazard ratio; Confidence interval; Clinical endpoint; Placebo; Quality of life (healthcare); Internal medicine; Randomized controlled trial; Cancer; Physical therapy; Chronic pain","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012998,0.0005891212,0.0009950977,0.0002198159,0.0001787326,0.0005505835,0.0004162056,0.0006216967,0.002549222],"category_scores_gemma":[0.001066914,0.0002380131,0.001320976,0.0004512498,0.0003372618,0.0004236759,0.0003555213,0.001488648,0.0002391869],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004865252,"about_ca_system_score_gemma":0.0007233598,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006191284,"about_ca_topic_score_gemma":0.00204468,"domain_scores_codex":[0.9996064,0.0002306201,0.00001841905,0.00004551225,0.00004064322,0.00005835703],"domain_scores_gemma":[0.9993667,0.00016569,0.000215323,0.00002572094,0.0000332569,0.0001933345],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.911107,0.005757695,0.03482788,0.001285555,0.003261875,0.0001115824,0.00008387907,0.001408545,0.002760843,0.00009689511,0.002120158,0.03717811],"study_design_scores_gemma":[0.5845132,0.2490603,0.1552025,0.0002100446,0.003999335,0.0003340827,0.0001239965,0.001928779,0.001580952,0.0003189193,0.002682366,0.00004556388],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929913,0.004593559,0.0001349447,0.0003022717,0.00006475063,0.000350701,0.0009945525,0.00001182292,0.000555957],"genre_scores_gemma":[0.9963132,0.001025746,0.0002093501,0.0001762128,0.00008964606,0.0004320112,0.001312777,0.000002075772,0.0004390145],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002549222,"threshold_uncertainty_score":0.008528054,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.266717536119669,"score_gpt":0.528010711439331,"score_spread":0.261293175319662,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}